Register
Login:
Share:
Email Facebook Twitter


UPDATE: #COPL set timeline for Q2/Q3 Nigeria drilling programme
RESULTS: IFA led wealth managers AFH Financial results show strong growth


Glaxosmithkline Directors Deals



Directors deals for Glaxosmithkline (GSK)


Share Price: 1,581.00Bid: 1,582.00Ask: 1,582.80Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.80Spread as %: 0.05%Open: 1,567.00High: 1,592.40Low: 1,567.00Yesterday’s Close: 1,581.00


Directors Deals for Glaxosmithkline (GSK)
Trade DateActionNotifierPriceCurrencyAmountHolding
13-Feb-19Buy
Trade Notifier Information for GlaxoSmithKline
Victoria Whyte held the position of Company Secretary at GlaxoSmithKline at the time of this trade.
 Victoria Whyte
1547GBX3,02039427
11-Feb-19Transfer From
Trade Notifier Information for GlaxoSmithKline
Victoria Whyte held the position of Company Secretary at GlaxoSmithKline at the time of this trade.
 Victoria Whyte
011,06041590
11-Feb-19Sell
Trade Notifier Information for GlaxoSmithKline
Victoria Whyte held the position of Company Secretary at GlaxoSmithKline at the time of this trade.
 Victoria Whyte
1553.8GBX5,19936391
11-Feb-19Buy
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
1554.33GBX8210945
11-Feb-19Transfer From
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
08210937
11-Feb-19Buy
Trade Notifier Information for GlaxoSmithKline
Simon Dingemans held the position of CFO at GlaxoSmithKline at the time of this trade.
 Simon Dingemans
1554.33GBX819849558
11-Feb-19Transfer From
Trade Notifier Information for GlaxoSmithKline
Simon Dingemans held the position of CFO at GlaxoSmithKline at the time of this trade.
 Simon Dingemans
0819849558
11-Feb-19Buy
Trade Notifier Information for GlaxoSmithKline
Victoria Whyte held the position of Company Secretary at GlaxoSmithKline at the time of this trade.
 Victoria Whyte
1554.33GBX836407
11-Feb-19Transfer From
Trade Notifier Information for GlaxoSmithKline
Victoria Whyte held the position of Company Secretary at GlaxoSmithKline at the time of this trade.
 Victoria Whyte
0836407
11-Feb-19Buy
Trade Notifier Information for GlaxoSmithKline
David Redfern held the position of Chief Strategy Officer at GlaxoSmithKline at the time of this trade.
 David Redfern
1554.33GBX8143097
11-Feb-19Transfer From
Trade Notifier Information for GlaxoSmithKline
David Redfern held the position of Chief Strategy Officer at GlaxoSmithKline at the time of this trade.
 David Redfern
08143097
07-Feb-19Sell
Trade Notifier Information for GlaxoSmithKline
Victoria Whyte held the position of Company Secretary at GlaxoSmithKline at the time of this trade.
 Victoria Whyte
1569.41GBX6,91023620
07-Feb-19Exercise of option
Trade Notifier Information for GlaxoSmithKline
Victoria Whyte held the position of Company Secretary at GlaxoSmithKline at the time of this trade.
 Victoria Whyte
1177GBX6,91030530
06-Feb-19Buy
Trade Notifier Information for GlaxoSmithKline
Philip R Hampton held the position of Non-Executive Chairman at GlaxoSmithKline at the time of this trade.
 Philip R Hampton
1495GBX2,9268765326
06-Feb-19Buy
Trade Notifier Information for GlaxoSmithKline
Vivienne Cox held the position of Independent Non-Executive Director at GlaxoSmithKline at the time of this trade.
 Vivienne Cox
1495GBX3552974


Registered members see more Glaxosmithkline directors deals!
Sign up here.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.